Literature DB >> 8213832

Genotype-phenotype relationships in fragile X syndrome: a family study.

D Z Loesch1, R Huggins, D A Hay, A K Gedeon, J C Mulley, G R Sutherland.   

Abstract

Relationships between the measures of intellectual and physical status in the fragile X syndrome and the size of amplification of the fragile X-specific fragment, equivalent to the number of CCG repeats within the FMR1 locus, were studied by a maximum-likelihood scoring technique for analysis of pedigree data. This allows for estimation of random effects (genetic and environmental variance) concurrently with other (fixed) effects in a quantitative trait. FMR1 expression is usually shut down in males penetrant for the fragile X syndrome who have hypermethylated CCG amplifications of > or = 0.6 kb. The assumption of the step versus curvilinear function representing this relationship was tested by the likelihood-ratio criterion. The maximum-likelihood parameters were based on the most appropriate model for each measure. The results were indicative of the presence of a curvilinear relationship between the amplification size and the two intellectual scores, the Peabody Picture Vocabulary Test and Block Design Test, measuring verbal and spatial abilities, respectively. Reasons for the unexpected curvilinear regression between the amplification size and intellectual scores were explained further by methylation analysis of fragile X males with amplifications of 0.6 < delta < or = 1.2 kb who appeared to be responsible for the curvilinearity of the relationship. Four of these showed unmethylated status of the amplified bands in lymphocytes, which were presumably transcriptionally active. Removal of the aberrant individuals led to the anticipated step function between amplification and intellectual scores. For the combined anthropometric score, as well as for several single physical measures, the step function was the most appropriate model regardless of the inclusion or omission of the aberrant individuals in the pedigree sample.

Entities:  

Mesh:

Year:  1993        PMID: 8213832      PMCID: PMC1682311     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  29 in total

1.  Extensions to pedigree analysis. III. Variance components by the scoring method.

Authors:  K Lange; J Westlake; M A Spence
Journal:  Ann Hum Genet       Date:  1976-05       Impact factor: 1.670

2.  Phenotypic variation in male-transmitted fragile X: genetic inferences.

Authors:  D Z Loesch; D A Hay; G R Sutherland; J Halliday; C Judge; G C Webb
Journal:  Am J Med Genet       Date:  1987-06

3.  Between-generation differences in ascertainment and penetrance: relevance to genetic hypotheses in fragile X.

Authors:  D Z Loesch; L J Sheffield; D A Hay
Journal:  Hum Genet       Date:  1993-06       Impact factor: 4.132

4.  Extensions to multivariate normal models for pedigree analysis.

Authors:  J L Hopper; J D Mathews
Journal:  Ann Hum Genet       Date:  1982-10       Impact factor: 1.670

5.  Neuropsychological dimensions of the fragile X syndrome: support for a non-dominant hemisphere dysfunction hypothesis.

Authors:  S F Crowe; D A Hay
Journal:  Neuropsychologia       Date:  1990       Impact factor: 3.139

6.  A premutation that generates a defect at crossing over explains the inheritance of fragile X mental retardation.

Authors:  M E Pembrey; R M Winter; K E Davies
Journal:  Am J Med Genet       Date:  1985-08

7.  Effect of fragile X on physical and intellectual traits estimated by pedigree analysis.

Authors:  D Z Loesch; R M Huggins; W F Chin
Journal:  Am J Med Genet       Date:  1993-06-01

8.  DNA methylation represses FMR-1 transcription in fragile X syndrome.

Authors:  J S Sutcliffe; D L Nelson; F Zhang; M Pieretti; C T Caskey; D Saxe; S T Warren
Journal:  Hum Mol Genet       Date:  1992-09       Impact factor: 6.150

9.  Cognitive profiles and the spectrum of clinical manifestations in heterozygous fra (X) females.

Authors:  M B Kemper; R J Hagerman; R S Ahmad; R Mariner
Journal:  Am J Med Genet       Date:  1986 Jan-Feb

10.  Application of the anthropometric discriminant functions in estimation of carrier probabilities in Martin-Bell syndrome.

Authors:  D Z Loesch; D Scott
Journal:  Clin Genet       Date:  1989-09       Impact factor: 4.438

View more
  25 in total

1.  Resolution of spatial and temporal visual attention in infants with fragile X syndrome.

Authors:  Faraz Farzin; Susan M Rivera; David Whitney
Journal:  Brain       Date:  2011-11       Impact factor: 13.501

2.  iPSC-derived forebrain neurons from FXS individuals show defects in initial neurite outgrowth.

Authors:  Matthew E Doers; Michael T Musser; Robert Nichol; Erich R Berndt; Mei Baker; Timothy M Gomez; Su-Chun Zhang; Leonard Abbeduto; Anita Bhattacharyya
Journal:  Stem Cells Dev       Date:  2014-04-30       Impact factor: 3.272

3.  Don't miss patients with atypical FMR1 mutations: dysmorphism and clinical features in a boy with a partially methylated FMR1 full mutation.

Authors:  Edda Haberlandt; Sibylle Zotter; Martina Witsch-Baumgartner; Johannes Zschocke; Dieter Kotzot
Journal:  Eur J Pediatr       Date:  2014-07-17       Impact factor: 3.183

4.  Unusual mutations in high functioning fragile X males: apparent instability of expanded unmethylated CGG repeats.

Authors:  D Wöhrle; U Salat; D Gläser; J Mücke; M Meisel-Stosiek; D Schindler; W Vogel; P Steinbach
Journal:  J Med Genet       Date:  1998-02       Impact factor: 6.318

5.  Mental status of females with an FMR1 gene full mutation.

Authors:  B B de Vries; A M Wiegers; A P Smits; S Mohkamsing; H J Duivenvoorden; J P Fryns; L M Curfs; D J Halley; B A Oostra; A M van den Ouweland; M F Niermeijer
Journal:  Am J Hum Genet       Date:  1996-05       Impact factor: 11.025

6.  FMR1 intron 1 methylation predicts FMRP expression in blood of female carriers of expanded FMR1 alleles.

Authors:  David E Godler; Howard R Slater; Quang M Bui; Michele Ono; Freya Gehling; David Francis; David J Amor; John L Hopper; Randi Hagerman; Danuta Z Loesch
Journal:  J Mol Diagn       Date:  2011-06-30       Impact factor: 5.568

Review 7.  Fragile X syndrome. Molecular and clinical insights and treatment issues.

Authors:  R J Hagerman
Journal:  West J Med       Date:  1997-02

8.  A multicenter study on genotype-phenotype correlations in the fragile X syndrome, using direct diagnosis with probe StB12.3: the first 2,253 cases.

Authors:  F Rousseau; D Heitz; J Tarleton; J MacPherson; H Malmgren; N Dahl; A Barnicoat; C Mathew; E Mornet; I Tejada
Journal:  Am J Hum Genet       Date:  1994-08       Impact factor: 11.025

9.  C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS/FTD.

Authors:  Elaine Y Liu; Jenny Russ; Kathryn Wu; Donald Neal; Eunran Suh; Anna G McNally; David J Irwin; Vivianna M Van Deerlin; Edward B Lee
Journal:  Acta Neuropathol       Date:  2014-05-08       Impact factor: 17.088

10.  Fragile-X syndrome: genetic aspects and stomatologic evaluations.

Authors:  F Muzzi; F Santini; G Romanini; F N Bartuli; C Arcuri
Journal:  Oral Implantol (Rome)       Date:  2011-01-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.